A major new investment into genomics research highlights the importance of genomics to New Zealand's future wellbeing and ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Targeted Genomics’ GlutenID test, designed to ...

Arima Genomics expands executive team with three strategic hires to advance clinical applications of 3D genomics.

Highly valued economically, ecologically and culturally, the white oak (Quercus alba) is a keystone forest species and is one ...

BGI Genomics' Indonesian joint venture NGI signed a partnership agreement for research collaboration with  Indonesian ...

New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects.

Genomics is bringing in a new wave of money from an unlikely group of investors — health systems. More providers are ...

Leerink Partnrs downgraded shares of 10x Genomics (NASDAQ:TXG – Free Report) from a strong-buy rating to a hold rating in a ...

Genomics (NASDAQ:TXG – Get Free Report) had its price objective reduced by Morgan Stanley from $28.00 to $26.00 in a research ...

Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from ...